Media Releases
Roche and the Zur Rose Group announce collaboration to offer innovative health journeys for people living with diabetes
Today, Roche and the Zur Rose Group announced a collaboration to empower people with diabetes and their caregivers in their daily therapy management. In Europe, there are 60 million people living with diabetes, i.e. approximately 9% of the population older than 20 years.
Roche launches mySugr Pump Control within the mySugr app to simplify insulin pump therapy via smartphone
mySugr now allows control of the Accu-Chek Insight insulin pump directly via smartphone, starting in Austria, bringing more discretion and simplicity to the life of people with diabetes.
Roche collaborates with Lilly to support people with diabetes on insulin pen therapy
Roche and Lilly will integrate data from Lilly’s connected insulin pen solution into the mySugr app in several countries. Both companies are dedicated to driving new possibilities to ease the complexity of daily decision making for people with diabetes on insulin pen therapy and their healthcare professionals.
Blog
Interview with Max: How does mySugr Pump Control help?
Max has been part of the mySugr Alpha Tester group for years and was one of the first who tried mySugr Pump Control. Read about his experiences in this interview.
Access to diabetes care
World Diabetes Day 2021
‘Access to Diabetes Care’ is one of the biggest challenges in managing this chronic condition around the globe. This year's World Diabetes Day draws attention to this.
EASD 2021: Integrating and personalising care to improve health outcomes along the diabetes journey
Roche Diabetes Care hosted the symposium "Personalising diabetes care along the entire patient journey" at the virtual Annual Meeting of the European Association for the Study of Diabetes (EASD) 2021.
